Monitoring Treatment Efficacy and Resistance in Breast Cancer Patients via Circulating Tumor DNA Genomic Profiling

Molecular genetics & genomic medicine - United States
doi 10.1002/mgg3.1079
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy via Profiling Circulating Cell-Free DNA in Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Tumor Genomic Profiling in Breast Cancer Patients Using Targeted Massively Parallel Sequencing

2014English

Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

HER2 Genomic Amplification in Circulating Tumor DNA From Patients With Cetuximab-Resistant Colorectal Cancer

Oncotarget
Oncology
2015English

Detection and Differential Diagnosis of Cancer Relapse Using Circulating Tumor DNA Profiling in a Patient With Synchronous Breast and Rectal Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Circulating Tumor Cells in Patients With Breast Cancer Dormancy

Clinical Cancer Research
Cancer ResearchOncology
2004English

Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma

Oncotarget
Oncology
2015English

Circulating Tumor Cells Detection in Tumor Draining Vein of Breast Cancer Patients

Scientific Reports
Multidisciplinary
2019English

Cancer Panel Analysis of Circulating Tumor Cells in Patients With Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy